Clinical trial
Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients
NCT00001837 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00001837 |
|---|---|
| Title | Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients |
| Official title | Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Breast Neoplasm |
| Enrollment | 60 |
| Start date | Nov 1, 1998 |
| Completion | Oct 1, 2005 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: